MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of May 21, 2026, MXCT trades at $1.07 with a market cap of $113.55M and a P/E ratio of -2.49. MXCT moved +1.44% today. Year to date, MXCT is -30.97%; over the trailing twelve months it is -50.92%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MXCT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MXCT recently traded at $1.07. Market cap is $113.55M. P/E ratio is -2.49. Revenue is $33.03M.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $113.55M |
| P/E Ratio | -2.49 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.20 |
| 52-Week Low | $0.64 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $33.03M |
| Net Income | $-44.63M |
| Gross Margin | 81.16% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $33.03M | $-44.63M | $-0.42 |
| 2024 | $38.63M | $-41.05M | $-0.39 |
| 2023 | $41.29M | $-37.92M | $-0.37 |
| 2022 | $44.26M | $-23.57M | $-0.23 |
5 analysts cover MXCT: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.